RBN Stock Chart & Stats
$1073.50
$0.00(0.00%)
At close: 4:00 PM EDT
$1073.50
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1,056.60 - $1,572.05
Previous CloseN/A
Volume0.00
Average Volume (3M)70.00
Market Cap
$862.07B
Enterprise Value$41.15B
Total Cash (Recent Filing)$878.00M
Total Debt (Recent Filing)$10.16B
Price to Earnings (P/E)12.1
Beta-0.13
Next Earnings
Feb 25, 2027EPS Estimate
48.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.46
Shares Outstanding633,354,860
10 Day Avg. Volume212
30 Day Avg. Volume70
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.26
Price to Sales (P/S)2.87
P/FCF Ratio23.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,556.81Price Target Upside45.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)84.3
Revenue Forecast (FY)$327.03B
Bulls Say, Bears Say
Bulls Say
Emerging-market GrowthStrong emerging-market growth provides a durable expansion engine beyond mature markets, supported by sustained momentum in China and India. Continued volume gains and broad geographic demand can improve scale, reinforce brand presence, and support revenue growth over the next several quarters.
Margin Improvement ProgramProfitability is supported by margin performance ahead of expectations and an ongoing cost program with a specific fixed-cost target. If execution continues, operating leverage can offset cost inflation, sustain stronger margins, and create greater capacity to fund innovation and brand investment.
Lower LeverageThe sharp reduction in debt relative to equity materially improves financial flexibility and reduces balance-sheet risk compared with prior years. Strong returns on equity further indicate effective use of the capital base, supporting resilience and more disciplined funding of operations and investment.
Bears Say
Weak Cash ConversionCash conversion of 42% means reported earnings are translating into substantially less cash in the current period. This can constrain internally funded investment and capital returns, while the divestment-related earnings effect creates a continuing headwind for near-term cash generation.
Input-cost Margin PressureInput-cost inflation and commodity volatility are directly reducing gross margins, creating pressure on profitability even when revenue grows. The need for pricing, productivity, or mix improvement to recover margin increases execution risk and may limit earnings growth over the next several quarters.
Household Care WeaknessThe Household Care decline shows that parts of the portfolio remain exposed to regional disruption and aggressive promotion. Persistent weakness in this category can dilute group growth, pressure realized pricing, and require additional commercial investment before performance stabilizes.
Reckitt News
RBN FAQ
What was Reckitt’s price range in the past 12 months?
Reckitt lowest stock price was $1056.60 and its highest was $1572.05 in the past 12 months.
What is Reckitt’s market cap?
Reckitt’s market cap is $862.07B.
When is Reckitt’s upcoming earnings report date?
Reckitt’s upcoming earnings report date is Feb 25, 2027 which is in 117 days.
How were Reckitt’s earnings last quarter?
Reckitt released its earnings results on Jul 29, 2026. The company reported $25.564 earnings per share for the quarter, missing the consensus estimate of $35.931 by -$10.367.
Is Reckitt overvalued?
According to Wall Street analysts Reckitt’s price is currently Undervalued.
Does Reckitt pay dividends?
Reckitt does not currently pay dividends.
What is Reckitt’s EPS estimate?
Reckitt’s EPS estimate is 48.68.
How many shares outstanding does Reckitt have?
Reckitt has 633,354,860 shares outstanding.
What happened to Reckitt’s price movement after its last earnings report?
Reckitt reported an EPS of $25.564 in its last earnings report, missing expectations of $35.931. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Reckitt?
Currently, no hedge funds are holding shares in MX:RBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckitt Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1,556.81 (45.02% Upside)
$1,556.81 (45.02% Upside)
Blogger Sentiment
Bullish
MX:RBN Sentiment 100%
Sector Average 63%
Sector Average 63%
Insider Transactions
Bought Shares
Worth $449.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 86%
Bearish news 14%
Bearish news 14%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.47%
12-Months-Change
Fundamentals
Return on Equity
42.87%
Trailing 12-Months
Asset Growth
-0.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Reckitt
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
RBN Stock 12 Month Forecast
Average Price Target
$1,556.81
▲(45.02% Upside)